AmerisourceBergen Launches New Platform To Boost Patient Support Services

Latest Startup Investment Opportunities:

• AmerisourceBergen Corporation ABC announced the launch of its Cell and Gene Therapy (CGT) Integration Hub. This platform facilitates real-time data exchange to reduce potential barriers across the patient journey.
• The platform allows physicians to expedite their investigation process with real-time visibility into therapy and treatment development.
•  Under the platform, AmerisourceBergen will offer support at each product lifecycle stage, including third-party logistics, regulatory consulting, and patient support services.
• "Our goal is to increase connectivity and reduce potential barriers across the patient journey," said Dale Hanna, Director of Cell & Gene Therapy Solutions at AmerisourceBergen.
• The company confirmed that it is on the verge of several landmark CGT approvals this year in the U.S., which reflects the rapid pace at which this sector is moving.
• Also Read: AmerisourceBergen, TPG To Acquire OneOncology From General Atlantic For $2.1B
• Price Action: ABC shares are up by 0.76% at $167.99 on the last check Monday.